| Literature DB >> 33404112 |
Mathieu Danoy1,2, Yannick Tauran1,3, Stéphane Poulain4,5, Rachid Jellali6, Johanna Bruce7, Marjorie Leduc7, Morgane Le Gall7, Francoise Gilard8, Taketomo Kido9, Hiroshi Arakawa10, Karin Araya10, Daiki Mori11, Yukio Kato10, Hiroyuki Kusuhara11, Charles Plessy4, Atsushi Miyajima9, Yasuyuki Sakai2, Eric Leclerc1,6.
Abstract
Maturation of human-induced pluripotent stem cells (hiPSCs)-derived hepatocytes-like cells (HLCs) toward a complete hepatocyte phenotype remains a challenge as primitiveness patterns are still commonly observed. In this study, we propose a modified differentiation protocol for those cells which includes a prematuration in Petri dishes and a maturation in microfluidic biochip. For the first time, a large range of biomolecular families has been extracted from the same sample to combine transcriptomic, proteomic, and metabolomic analysis. After integration, these datasets revealed specific molecular patterns and highlighted the hepatic regeneration profile in biochips. Overall, biochips exhibited processes of cell proliferation and inflammation (via TGFB1) coupled with anti-fibrotic signaling (via angiotensin 1-7, ATR-2, and MASR). Moreover, cultures in this condition displayed physiological lipid-carbohydrate homeostasis (notably via PPAR, cholesterol metabolism, and bile synthesis) coupled with cell respiration through advanced oxidative phosphorylation (through the overexpression of proteins from the third and fourth complex). The results presented provide an original overview of the complex mechanisms involved in liver regeneration using an advanced in vitro organ-on-chip technology.Entities:
Keywords: differentiation; hepatocytes; iPSCs; liver; metabolomics; nanoCAGE; organ-on-chip; proteomics; transcriptomics
Mesh:
Year: 2021 PMID: 33404112 DOI: 10.1002/bit.27667
Source DB: PubMed Journal: Biotechnol Bioeng ISSN: 0006-3592 Impact factor: 4.530